Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T17:02:45.087Z.
Calculation as of: 2026-10-06T17:02:45.087Z.
Quote observation: 2026-10-06T17:00:44.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 88e906b5462319013e69f4ee379284aaffb96e00f9acc248208650345dd3e90c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$6.57B
Price/FCF Ratio
73.14
TTM Avg
78.27
3Y Avg
69.99
5Y Avg
72.53
Market Cap
$6.50B
Price/FCF Ratio
16.77
TTM Avg
14.30
3Y Avg
15.40
5Y Avg
29.38
Market Cap
$6.49B
Price/FCF Ratio
78.10
TTM Avg
27.87
3Y Avg
16.49
5Y Avg
12.82
Market Cap
$6.23B
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.94B
Price/FCF Ratio
45.25
TTM Avg
84.29
3Y Avg
54.39
5Y Avg
39.76
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunovant, Inc. (IMVT) | $6.55B | N/A | N/A | N/A | N/A |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.57B | 73.14 | 78.27 | 69.99 | 72.53 |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.50B | 16.77 | 14.30 | 15.40 | 29.38 |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.49B | 78.10 | 27.87 | 16.49 | 12.82 |
| Chemed Corporation (CHE)vs › | $6.65B | 20.55 | 17.97 | 25.26 | 27.45 |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.23B | N/A | N/A | N/A | N/A |
| Alkermes plc (ALKS)vs › | $6.97B | 31.45 | 20.74 | 16.27 | 40.65 |
| GRAIL Inc. (GRAL)vs › | $6.01B | N/A | N/A | N/A | N/A |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.94B | 45.25 | 84.29 | 54.39 | 39.76 |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.92B | N/A | 1.10 | 1.10 | 1.10 |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
